China Biologic Products Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on China Biologic Products Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how China Biologic Products Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with China Biologic Products Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Taibang Biologic Group (Taibang Biologic) formerly, China Biologic Products Holdings Inc, discovers, develops, manufactures and sells human plasma-based biopharmaceutical products. Focus on research and development activities, plasma and plasma-derived products, and diversified product portfolio are its strengths, even as private ownership restricts ability to raise funds could be an area of concern for the company. Taibang Biologic can benefit from demand of plasma derivatives, positive outlook of the global pharmaceutical market, and global neurological devices market. However, stiff competition, stringent regulations, and reliance on third party manufacturers could hamper its growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer